About this Research Topic
Targeting molecules for disease diagnosis and treatment is a rapidly growing area in biomedical science. This approach involves identifying the specific molecules or biomarkers associated with a particular disease or condition and then developing targeted therapies or diagnostic tests to detect or treat those molecules effectively. By targeting specific molecules, personalized medicine offers the potential to improve patient outcomes, reduce treatment-related side effects, and minimize healthcare costs. Advancements in genomic analysis, proteomics, and metabolomics have enabled identifying specific molecules or biomarkers associated with a particular disease. At the same time, confocal microscopy can reveal organelle-targeting molecular probes with different physicochemical properties. Using these technologies, we can develop other targeted drug probes to diagnose and treat diseases.
Targeting molecules for disease diagnosis and treatment holds great promise for revolutionizing medicine by providing personalized and effective therapies for various diseases and conditions. However, obstacles range from identifying specific biomarkers or molecules and heterogeneity across individuals to expensive and time-consuming clinic trials, drug design, and delivery methods. Overall, overcoming the obstacles associated with targeting molecules for disease diagnosis and treatment requires a collaborative effort between researchers, clinicians, pharmaceutical companies, patients, and government agencies. Working together can improve patient outcomes and revolutionize how we diagnose and treat diseases. This approach can potentially transform the healthcare industry by providing patients with more personalized and effective therapies.
This issue aims to address the current state and future potential of targeting molecules for disease diagnosis and treatment. We welcome submissions that explore the identification of specific molecules or biomarkers associated with diseases, developing and testing targeted therapies and diagnostic tests, and the challenges and opportunities related to personalized medicine. We are interested in original research articles, reviews, perspectives, and opinion pieces that provide novel insights into the field. Manuscripts may cover a range of topics, including but not limited to:
• Advancements in genomic analysis, proteomics, and metabolomics for identifying specific molecules or biomarkers
• Development and application of diagnostic reagents/functional fluorescent probes
• New clinical avenues for targeted therapy and drug delivery We encourage authors to submit work highlighting the importance of collaboration between researchers, clinicians, and pharmaceutical companies to accelerate the development and implementation of targeted therapies.
Targeting molecules for disease diagnosis and treatment holds great promise for revolutionizing medicine by providing personalized and effective therapies for various diseases and conditions. However, obstacles range from identifying specific biomarkers or molecules and heterogeneity across individuals to expensive and time-consuming clinic trials, drug design, and delivery methods. Overall, overcoming the obstacles associated with targeting molecules for disease diagnosis and treatment requires a collaborative effort between researchers, clinicians, pharmaceutical companies, patients, and government agencies. Working together can improve patient outcomes and revolutionize how we diagnose and treat diseases. This approach can potentially transform the healthcare industry by providing patients with more personalized and effective therapies.
This issue aims to address the current state and future potential of targeting molecules for disease diagnosis and treatment. We welcome submissions that explore the identification of specific molecules or biomarkers associated with diseases, developing and testing targeted therapies and diagnostic tests, and the challenges and opportunities related to personalized medicine. We are interested in original research articles, reviews, perspectives, and opinion pieces that provide novel insights into the field. Manuscripts may cover a range of topics, including but not limited to:
• Advancements in genomic analysis, proteomics, and metabolomics for identifying specific molecules or biomarkers
• Development and application of diagnostic reagents/functional fluorescent probes
• New clinical avenues for targeted therapy and drug delivery We encourage authors to submit work highlighting the importance of collaboration between researchers, clinicians, and pharmaceutical companies to accelerate the development and implementation of targeted therapies.
Keywords: Therapeutic reagents and fluorescence probes, Disease diagnosis and treatment, Targeted therapy and drug delivery, Pharmaceutical analysis and evaluation, Cancer and inflammation
Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.
